 |
|
Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
Paul Y. Kwo
Clin Mol Hepatol. 2024;30(4):714-717. Published online 2024 Jun 11 DOI: https://doi.org/10.3350/cmh.2024.0425
|
|
Citations to this article as recorded by
 Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
Seren M. Gedallovich, Paul Y. Kwo
Clinical and Molecular Hepatology.2024; 30(4): 1050. CrossRef Metformin in Antiviral Therapy: Evidence and Perspectives
Iryna Halabitska, Pavlo Petakh, Oleh Lushchak, Iryna Kamyshna, Valentyn Oksenych, Oleksandr Kamyshnyi
Viruses.2024; 16(12): 1938. CrossRef
|